{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:44:00Z","timestamp":1761709440134,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["F 3513-B11","F 3513-B20","I 1609-B24"],"award-info":[{"award-number":["F 3513-B11","F 3513-B20","I 1609-B24"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsche Forschungsgesellschaft","award":["DFG PA930\/9-1"],"award-info":[{"award-number":["DFG PA930\/9-1"]}]},{"name":"Lower Austria Corporation for Research and Education","award":["LS14-008","LS15-003"],"award-info":[{"award-number":["LS14-008","LS15-003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejps.2018.01.034","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T09:16:27Z","timestamp":1517390187000},"page":"212-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice"],"prefix":"10.1016","volume":"115","author":[{"given":"Severin","family":"Mairinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Zoufal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Traxl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Filip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sauberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kuntner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Pahnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-5781","authenticated-orcid":false,"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.01.034_bb0005","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","article-title":"Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up","volume":"17","author":"Agarwal","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2018.01.034_bb0010","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2018.01.034_bb0015","doi-asserted-by":"crossref","first-page":"20801","DOI":"10.1073\/pnas.1312159110","article-title":"Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2","volume":"110","author":"Bakhsheshian","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2018.01.034_bb0020","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2967\/jnumed.108.051235","article-title":"Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET","volume":"49","author":"Bankstahl","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2018.01.034_bb0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2967\/jnumed.112.118232","article-title":"Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier","volume":"54","author":"Bauer","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2018.01.034_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clpt.2005.04.011","article-title":"Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans","volume":"78","author":"Brunner","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.01.034_bb0035","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.109.154781","article-title":"P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib","volume":"330","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2018.01.034_bb0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/mol.115.102079","article-title":"Generation and characterization of a breast cancer resistance protein humanized mouse model","volume":"89","author":"Dallas","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.034_bb0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.034_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2018.01.034_bb0055","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/dmd.108.020974","article-title":"Investigation of the role of breast cancer resistance protein (Bcrp\/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse","volume":"36","author":"Giri","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.034_bb0060","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ejps.2013.08.015","article-title":"[11C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats","volume":"50","author":"Hosten","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.034_bb0065","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jps.10176","article-title":"A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro","volume":"91","author":"Hugger","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.034_bb0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0883-2889(92)90012-4","article-title":"A simple synthesis of [11C]methyl triflate","volume":"43","author":"Jewett","year":"1992","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejps.2018.01.034_bb0075","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1021\/mp400011g","article-title":"Factors that limit positron emission tomography imaging of p-gycoprotein density at the blood-brain barrier","volume":"10","author":"Kannan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.01.034_bb0080","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2018.01.034_bb0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.109.162321","article-title":"Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone","volume":"333","author":"Kodaira","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2018.01.034_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/clpt.2013.85","article-title":"Imaging in the study of membrane transporters","volume":"94","author":"Kusuhara","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 7","key":"10.1016\/j.ejps.2018.01.034_bb0095","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1002\/jcph.722","article-title":"Use of PET imaging to evaluate transporter-mediated drug-drug interactions","volume":"56","author":"Langer","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.034_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/dmd.114.062174","article-title":"Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design","volume":"43","author":"Lee","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.034_bb0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/dmd.111.044420","article-title":"Use of the cassette-dosing approach to assess brain penetration in drug discovery","volume":"40","author":"Liu","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.034_bb0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/dmd.113.055590","article-title":"Use of cassette dosing approach to examine the effects of P-glycoprotein on the brain and cerebrospinal fluid concentrations in wild-type and P-glycoprotein knockout rats","volume":"42","author":"Liu","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.034_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.dmpk.2017.02.003","article-title":"Metabolism of KO143, an ABCG2 inhibitor","volume":"32","author":"Liu","year":"2017","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.01.034_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.ejps.2018.01.034_bb0125","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2018.01.034_bb0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0969-8051(03)00078-7","article-title":"(R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation","volume":"30","author":"Luurtsema","year":"2003","journal-title":"Nucl. Med. Biol."},{"author":"Mairinger","key":"10.1016\/j.ejps.2018.01.034_bb0135"},{"key":"10.1016\/j.ejps.2018.01.034_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nucmedbio.2010.02.008","article-title":"Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)am ino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate","volume":"37","author":"Mairinger","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2018.01.034_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport\u2014an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.01.034_bb0150","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.034_bb0155","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.nucmedbio.2013.05.005","article-title":"Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats","volume":"40","author":"M\u00fcllauer","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2018.01.034_bb0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt.73","article-title":"Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier","volume":"97","author":"Raaphorst","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ejps.2018.01.034_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ph10030076","article-title":"Comparison of in vitro assays in selecting radiotracers for in vivo P-glycoprotein PET imaging","volume":"10","author":"Raaphorst","year":"2017","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2018.01.034_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.nucmedbio.2013.05.012","article-title":"(R)-[11C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP","volume":"40","author":"R\u00f6mermann","year":"2013","journal-title":"Nucl. Med. Biol."},{"year":"2010","series-title":"Infusion formulation of a specific BCRP inhibitor enables mechanistic investigation of clearance mechanism in vivo [symposium abstract]","author":"Shimanovich","key":"10.1016\/j.ejps.2018.01.034_bb0175"},{"key":"10.1016\/j.ejps.2018.01.034_bb0180","first-page":"2538","article-title":"Quantitative evaluation of mMate1 function based on minimally invasive measurement of tissue concentration using PET with [11C]metformin in mouse","volume":"32","author":"Shingaki","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.034_bb0185","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.addr.2013.09.002","article-title":"Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing \u201cGenerally Recognized As Safe\u201d (GRAS) nanopharmaceuticals: a review","volume":"65","author":"Sosnik","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.01.034_bb0190","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.apradiso.2010.03.012","article-title":"Radiosynthesis of [2-11C-carbonyl]dantrolene using [11C]phosgene for PET","volume":"68","author":"Takada","year":"2010","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejps.2018.01.034_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2967\/jnumed.112.110254","article-title":"Evaluation of breast cancer resistance protein function in hepatobiliary and renal excretion using PET with 11C-SC-62807","volume":"54","author":"Takashima","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2018.01.034_bb0200","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1021\/acs.molpharmaceut.5b00059","article-title":"PET tracers to study clinically relevant hepatic transporters","volume":"12","author":"Testa","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.01.034_bb0205","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2967\/jnumed.115.161273","article-title":"Breast cancer resistance protein and P-glycoprotein influence in vivo disposition of 11C-erlotinib","volume":"56","author":"Traxl","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2018.01.034_bb0210","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1124\/dmd.117.077081","article-title":"Hepatocyte-specific deletion of EGFR in mice reduces hepatic Abcg2 transport activity measured by [11C]erlotinib and positron emission tomography","volume":"45","author":"Traxl","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.034_bb0215","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/jcbfm.2012.112","article-title":"A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier","volume":"32","author":"Wanek","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2018.01.034_bb0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jlcr.2993","article-title":"Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood\u2013brain barrier","volume":"56","author":"Wanek","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejps.2018.01.034_bb0225","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/acs.molpharmaceut.5b00168","article-title":"Factors governing p-glycoprotein-mediated drug-drug interactions at the blood-brain barrier measured with positron emission tomography","volume":"12","author":"Wanek","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.01.034_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/jpet.115.225482","article-title":"The inhibitor Ko143 is not specific for ABCG2","volume":"354","author":"Weidner","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2011","series-title":"Use or misuse of Ko143 for Bcrp chemical knockout mice [symposium abstract]","author":"Zhang","key":"10.1016\/j.ejps.2018.01.034_bb0235"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718300411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718300411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T17:55:12Z","timestamp":1720029312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718300411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":47,"alternative-id":["S0928098718300411"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.01.034","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}